Finance

Beta
Lists
153710:KOSDAQ
Optipharm Co Ltd
₩4,445.00
-1.66%
(-75.00) 1D
Jun 10, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 153710...
Open
₩4,565
High
₩4,730
Low
₩4,385
Mkt. cap
65.21B
Avg. vol.
24.96K
Volume
12.16K
52-wk high
₩6,250
52-wk low
₩4,255
EPS
-₩144
Shares outstanding
14.67M
No. of employees
79
Open
₩4,565
High
₩4,730
Low
₩4,385
Mkt. cap
65.21B
Avg. vol.
24.96K
Volume
12.16K
52-wk high
₩6,250
52-wk low
₩4,255
EPS
-₩144
Shares outstanding
14.67M
No. of employees
79
News stories
From sources across the web
About Optipharm Co Ltd
CEO-
Employees79
Founded2000
Headquarters-
SectorBiotechnology
Websiteoptipharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.79B
5.68B
5.96B
5.36B
Cost of goods sold
4.14B
4.34B
4.31B
4.22B
Cost of revenue
4.14B
4.34B
4.31B
4.22B
Research and development expenses
816.60M
577.36M
688.38M
673.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11B
1.10B
1.11B
1.03B
Operating expense
2.08B
1.87B
1.97B
1.87B
Total operating expenses
6.22B
6.20B
6.28B
6.08B
Operating income
-433.98M
-524.99M
-321.12M
-723.40M
Other non operating income
12.60M
19.65M
22.14M
14.00M
EBT including unusual items
-470.33M
-547.20M
-343.25M
-753.91M
EBT excluding unusual items
-453.33M
-547.29M
-344.24M
-753.88M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
50.91M
68.71M
43.71M
38.02M
Net income
-470.33M
-547.20M
-343.25M
-753.91M
Net profit margin
-8.12%
-9.64%
-5.76%
-14.06%
Earnings per share
-
-
-
-
Interest and investment income
96.12M
85.02M
76.96M
74.99M
Interest expense
-126.87M
-126.16M
-122.50M
-119.45M
Net interest expenses
-30.75M
-41.14M
-45.54M
-44.45M
Depreciation and amortization charges
105.70M
119.16M
120.53M
119.32M
EBITDA
-24.42M
-102.01M
102.96M
-301.06M
Gain or loss from assets sale
16.99M
-95.00K
-990.00K
24.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer